D-0109-2027 Class III Ongoing

Recalled by Meitheal Pharmaceuticals, Inc — Chicago, IL

FDA drug recall D-0109-2027 was initiated by Meitheal Pharmaceuticals, Inc on Oct 8, 2026 and is designated Class III. Reason for recall: Labeling: Label Lacks Warning or Rx Legend The recall status is ongoing. Affected quantity: 10,200 vials.

Recall Details

Product Type
Drugs
Report Date
Nov 4, 2026
Initiation Date
Oct 8, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10,200 vials

Product Description

Vecuronium Bromide for Injection, 20mg, 10 Single-Dose Vials per carton, Sterile, Rx Only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL. NDC: 71288-745-21

Reason for Recall

Labeling: Label Lacks Warning or Rx Legend

Distribution Pattern

US. Nationwide

Code Information

Lot# T1P0113C: Exp. 28-Feb-29 Lot# T1P0612C: Exp. 31-Oct-28

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0109-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0109-2027. Report a data issue: hello@regdatalab.com.